Discover
PCSA
Processa Pharmaceuticals, Inc.
1.52
2 x 1.13
11 x 1.50
bid
ask
+
0.17
12.59%
7 @ 07:34 PM
1.46 -0.06 (3.95%)
| Ytd | -47.22% | |
| 1y | -84.52% |
1.04
day range
1.86
1.35
52 week range
11.02
| Open | 1.27 | Prev Close | 1.35 | Low | 1.04 | High | 1.86 | Mkt Cap | 4.25M |
| Vol | 2.97M | Avg Vol | 224.04K | EPS | -4.73 | P/E | N/A | Forward P/E | -0.39 |
| Beta | 0.60 | Short Ratio | 2.45 | Inst. Own | 1.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.02 | 200-d Avg | 2.49 | 1yr Est | 6.00 |
| Income Statement | |||
| Operating Expenses | 2.34M | ||
| Research and Development Expense | 649.88K | ||
| Selling, General and Administrative Expense | 1.69M | ||
| Operating Income | -2.34M | ||
| Interest Expense | 2.00K | ||
| Net Income | -3.27M | ||
| Net Income Common Stock | -3.27M | ||
| Net Income Common Stock (USD) | -3.27M | ||
| Consolidated Income | -3.27M | ||
| Earnings per Basic Share | -1.19 | ||
| Earnings per Basic Share (USD) | -1.19 | ||
| Earnings per Diluted Share | -1.19 | ||
| Earning Before Interest & Taxes (EBIT) | -3.26M | ||
| Earning Before Interest & Taxes (USD) | -3.26M | ||
| Weighted Average Shares | 2.75M | ||
| Weighted Average Shares Diluted | 2.75M | ||
| Balance Sheet | |||
| Cash and Equivalents | 196.33K | ||
| Cash and Equivalents (USD) | 196.33K | ||
| Investments | 472.00K | ||
| Investments Current | 472.00K | ||
| Current Assets | 2.07M | ||
| Property, Plant & Equipment Net | 3.21K | ||
| Total Assets | 2.07M | ||
| Current Liabilities | 2.39M | ||
| Total Liabilities | 2.39M | ||
| Accumulated Retained Earnings (Deficit) | -107.43M | ||
| Shareholders Equity | -317.34K | ||
| Shareholders Equity (USD) | -317.34K | ||
| Assets Non-Current | 3.21K | ||
| Trade and Non-Trade Payables | 1.66M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 301.00 | ||
| Net Cash Flow from Financing | 315.17K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.49M | ||
| Issuance (Purchase) of Equity Shares | 315.17K | ||
| Net Cash Flow from Investing | 186.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 186.00K | ||
| Net Cash Flow from Operations | -2.00M | ||
| Share Based Compensation | 92.11K | ||